BPG is committed to discovery and dissemination of knowledge
Citation
Yang HJ, Ye B, Liao JX, Lei L, Chen K. Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis. World J Hepatol 2024; 16(1): 91-102 [PMID: 38313249 DOI: 10.4254/wjh.v16.i1.91]
Please LOGIN to submit a new comment.